Anzeige
Mehr »
Login
Samstag, 09.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Der vergessene Kupferriese: Wie die 4,6-Milliarden-Pfund-Entdeckung dieses Unternehmens die KI-Revolution retten könnte!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AM00 | ISIN: SE0008241558 | Ticker-Symbol: 4A1
Frankfurt
08.11.24
08:05 Uhr
0,420 Euro
-0,006
-1,32 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CERENO SCIENTIFIC AB Chart 1 Jahr
5-Tage-Chart
CERENO SCIENTIFIC AB 5-Tage-Chart

Aktuelle News zur CERENO SCIENTIFIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCereno Scientific's CEO on novel therapies for rare diseases1
31.10.Cereno Scientific participates at DNB Nordic Healthcare Conference 20242
30.10.Cereno Scientific presents at BioStock Life Science Summit 20241
25.10.Edison Investment Research increases valuation of Cereno Scientific to 4.05 BSEK or SEK 14.3 SEK/share after IPF selected as initial target indication for CS0142
25.10.Cereno Scientific - CMD highlights a 'rare' portfolio refocus221Cereno Scientific recently held a capital markets day (CMD), providing greater insight on its development pipeline and strategic objectives. The key takeaway was its decision to focus on the rare disease...
► Artikel lesen
22.10.CERENO SCIENTIFIC: BioStock has published an interview with CEO Sten R. Sörensen on IPF as the initial indication for CS014 and the Company's strengthened focus on rare diseases3
22.10.The temperature of Cereno Scientific after major news1
17.10.Cereno Scientific presents an updated agenda for the Capital Markets Day October 17th, 20241
16.10.Cereno Scientific to attend BIO-Europe in Stockholm, November 4-6, 20241
15.10.Cereno Scientific presents the agenda for the upcoming Capital Markets Day to be held October 17th, 20242
09.10.Cereno Scientific to present preclinical data for drug candidate CS585 at the AHA Scientific Sessions 20242
08.10.Invitation to Cereno Scientific's Capital Markets Day on October 17, 20243
07.10.Edison Investment Research publishes Executive interview with Sten R. Sörensen, CEO, Cereno Scientific, on positive topline Phase IIa results1
03.10.Cereno Scientific discusses phase IIa results for CS11
03.10.CERENO SCIENTIFIC: Cereno's phase IIa results positive, clear path forward1
03.10.BioStock has published an article and interview with CEO Sten R. Sörensen on the positive topline results from Cereno Scientific's Phase IIa trial on CS1 in PAH1
02.10.Cereno Scientific - CS1 shines in Phase IIa PAH trial224Cereno Scientific has reported positive top-line results for the Phase IIa CS1-003 trial, which evaluated the HDAC inhibitor CS1 in pulmonary arterial hypertension (PAH). The primary endpoint of safety...
► Artikel lesen
02.10.Edison Investment Research increases valuation of Cereno Scientific to 3.9 BSEK or SEK 13.9 SEK/share after positive topline data1
30.09.Cereno's HDAC inhibitor reduces risks from pulmonary arterial hypertension in phase 2 trial2
30.09.Save the date for Cereno Scientific's Capital Markets Day on October 17, 20241
Seite:  Weiter >>
60 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1